https://www.selleckchem.com/pr....oducts/msc2530818.ht
significantly higher than that in the control group (all P0.05). No adverse events were reported in either group during the whole trial or follow-up period. HSLI had the advantages of preserving the skin of anal canal completely, alleviating postsurgical pain and promoting rapid recovery after operation. (Registration No. ChiCTR1900022883). HSLI had the advantages of preserving the skin of anal canal completely, alleviating postsurgical pain and promoting rapid recovery after operation. (Registration No. ChiCTR1900022883).Intravi
Mi piace
Commento
Condividi
